Jobs at Regulus Therapeutics | Ladders
Regulus Therapeutics

Why work for us

Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a biopharmaceutical company focused on the development of microRNA-based drugs targeting fibrosis, metabolism and cardiovascular diseases, cancer, HCV and immune-related diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. MicroRNAs are small naturally occurring RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead have evolved to regulate gene expression. Anti-miR therapeutics inhibit specific microRNA targets. Animal models showed that modulating microRNAs through anti-miRs effectively regulates biological processes and provides therapeutic benefit to cardiac dysfunction, cancer and hepatitis C virus infection. Administration of anti-miR oligonucleotides is possible through local or parenteral injection.

Snapshot

Employees: 61
Market Cap: $34.2 million
Revenue: $72,000
5 Year Trend: -64.46 %
Net Income: $-69.4 million
NASDAQ: RGLS
Jobs at Regulus Therapeutics
There are no jobs at the current time